Is it safe to administer isosorbide dinitrate (ISDN) to a patient with bradycardia?

ISDN Should NOT Be Given to Patients with Bradycardia

You are correct - isosorbide dinitrate (ISDN) is contraindicated or should be used with extreme caution in bradycardic patients, as it can cause paradoxical bradycardia and potentially life-threatening complications.

The Core Problem: Paradoxical Bradycardia

ISDN causes vasodilation that dramatically reduces venous return and left ventricular filling. This triggers a vagal reflex response that can cause severe bradycardia, especially in patients who already have a slow heart rate 1. The FDA drug label explicitly warns that "hypotension induced by isosorbide dinitrate may be accompanied by paradoxical bradycardia" 1.

Clinical Evidence of Harm

Multiple case reports document severe complications:

• Complete heart block and asystole: A 71-year-old woman developed ventricular asystole within 2 minutes of receiving 5mg sublingual ISDN, requiring precordial thump and atropine for resuscitation 2

• Severe hypotension with bradycardia: In a study of 100 acute MI patients, 14% developed severe hypotension with absolute or relative bradycardia after ISDN, with one patient experiencing syncope 3

• Vagally-mediated reflex: Research demonstrates that ISDN can trigger severe, reversible bradycardia through vagal reflexes initiated by markedly diminished ventricular filling 4

Why This Happens

The mechanism is straightforward:

1. ISDN causes profound venous dilation
2. Venous return drops precipitously
3. Left ventricular end-diastolic volume and pressure plummet
4. Mechanoreceptors detect the sudden drop in cardiac filling
5. A vagal reflex is triggered, causing severe bradycardia
6. This creates a dangerous spiral: bradycardia + hypotension + reduced cardiac output

When Bradycardia Patients Need Rate Support

The 2018 ACC/AHA/HRS bradycardia guidelines provide clear alternatives for symptomatic bradycardia 5, 6:

First-line therapy:

• Atropine 0.5-1 mg IV (may repeat every 3-5 minutes to maximum 3 mg)

Second-line options for patients at low risk of coronary ischemia:

• Isoproterenol: 20-60 mcg IV bolus or 1-20 mcg/min infusion
• Dopamine: 5-20 mcg/kg/min IV
• Epinephrine: 2-10 mcg/min IV

Note the critical caveat: These beta-agonists should be avoided if coronary ischemia is suspected, as they increase myocardial oxygen demand 6.

Critical Pitfall to Avoid

Never give ISDN to treat angina in a patient with bradycardia without first addressing the heart rate. The combination of:

• Pre-existing bradycardia
• ISDN-induced vasodilation
• Paradoxical worsening of bradycardia
• Hypotension

...creates a perfect storm for cardiovascular collapse requiring aggressive resuscitation 2, 3.

Bottom Line

If your patient has bradycardia and needs vasodilation or anti-anginal therapy, address the bradycardia FIRST with atropine or pacing before considering any nitrate therapy. Better yet, avoid nitrates entirely in bradycardic patients and use alternative anti-anginal strategies once heart rate is normalized.